Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01308983Phase 4Unknown
Phase 4, open-label, single-arm trial of amiloride in prehypertension, sponsored by Augusta University. Primary endpoint: Vascular phenotypes at 16 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01308983.